Shares of ReWalk Robotics Ltd. (NASDAQ:RWLK) saw strong trading volume on Tuesday . 152,090 shares changed hands during mid-day trading, an increase of 22% from the previous session’s volume of 124,960 shares.The stock last traded at $6.21 and had previously closed at $6.40.

Several equities research analysts have recently weighed in on the company. Jefferies Group reiterated a “buy” rating and issued a $16.00 price objective on shares of ReWalk Robotics in a research note on Sunday, May 8th. Zacks Investment Research lowered ReWalk Robotics from a “buy” rating to a “hold” rating in a research note on Thursday, July 7th. Piper Jaffray Cos. started coverage on ReWalk Robotics in a report on Friday, July 15th. They issued an “overweight” rating and a $10.00 target price on the stock. Finally, Canaccord Genuity reissued a “buy” rating on shares of ReWalk Robotics in a report on Sunday, August 7th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $12.80.

The firm’s market cap is $77.89 million. The company has a 50-day moving average of $6.69 and a 200 day moving average of $8.36.

ReWalk Robotics (NASDAQ:RWLK) last issued its quarterly earnings data on Thursday, August 4th. The medical device company reported ($0.64) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.53) by $0.11. The business had revenue of $0.82 million for the quarter, compared to analysts’ expectations of $1.95 million. ReWalk Robotics’s quarterly revenue was up 34.4% compared to the same quarter last year. On average, analysts anticipate that ReWalk Robotics Ltd. will post ($2.34) earnings per share for the current fiscal year.

In other ReWalk Robotics news, Director Wayne Weisman sold 16,148 shares of the firm’s stock in a transaction that occurred on Friday, May 20th. The shares were sold at an average price of $9.09, for a total transaction of $146,785.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Scp Vitalife Partners (Israel) sold 4,043 shares of the firm’s stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $9.09, for a total transaction of $36,750.87. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.